Legal Representation
Attorney
Nathan T. Harris
USPTO Deadlines
Next Deadline
23 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
December 01, 2025
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 1, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 1, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 4, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 4, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 5, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 10, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 10, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 20, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 6, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 6, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 7, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 13, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceuticals in the nature of an injectable solution for intravitreal use for the prevention of eye conditions including proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and retinitis pigmentosa
Classification
International Classes
005